Lidocaine/Heparin
利多卡因/肝素
Report date: 2026/02/13 10:40:15
Base Information
Drug NameLidocaine/Heparin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes Heparin sodiumLidocaine
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUrigenVaneltix Pharma IncPrevail Infoworks Inc
China Registration ClassN/A
Develop Information
Active CompaniesTcm Biotech International CorpVaneltix Pharma IncUS Army Medical Research Institute of Infectious Diseases
Inactive CompaniesUrigen
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A